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Summary 
The transporter associated with antigen processing (TAP) delivers peptides to the lumen of the 
endoplasmic reticuhm in an adenosine triphosphate (ATP) dependent fashion for presentation 
by major histocompatibility  complex class I molecules. We show that the mouse TAP translocator 
(H-2  b haplotype) sdects peptides based on a minimal size of nine residues, and on the presence 
of a hydrophobic COOH-terminal amino add. The preponderance of COOH-terminal hydrophobic 
amino acids in peptides capable of binding to mouse class I molecules thus fits remarkably well 
with the specificity of the TAP translocator.  In addition to transport in the lumenal direction, 
eit]ux of peptide in the cytosolic direction is observed in an ATP- and temperature-dependent 
manner. By maintaining a low peptide concentration at the site of class I assembly, this efl:hx 
mechanism may ensure that class I molecules are loaded preferentially with high affinity peptides. 
T 
he involvement of the MHC-encoded peptide transporter 
subunits associated with antigen processing (TAP1 and 
TAP2)  1 in class I MHC-restricted antigen presentation is 
well established.  Mutant cell lines defective in the synthesis 
of TAP subunits fail to engage in self-restricted antigen pre- 
sentation (1-4), and this defect is restored upon transfection 
with the corresponding wild-type cDNAs (5-10). However, 
these studies using TAP mutant and wild-type cell lines could 
not make a distinction between a peptide translocating and 
a class I loading function for the TAP gene products. Re- 
cently, mice with a targeted deletion in the TAP1 gene were 
produced and shown to have drastically reduced expression 
of class I molecules (11) and consequently they fail to develop 
a normal CD8 + T cell repertoire (12). Microsomes prepared 
from the liver of these TAP1 mutant mice and a comparison 
with similar preparations from wild-type mice allowed us 
to demonstrate that peptide translocation is ATP dependent, 
and requires the presence of a functional TAP1 gene product 
(13). A  similar ATP dependency and spedficity of peptide 
uptake was observed in experiments using TAP- cell lines 
1  Abbreviations  used in this  paper: ~2m, ~z-microglobulin; ER, endophsmic 
reticuhm; TAP, transporter associated with antigen processing. 
and TAP1/TAP2 transfectants thereof (14). These experiments 
have indicated that there is specifidty in the TAP-mediated 
translocation mechanism because peptides of different length 
and sequence do not compete (13) and are not taken up (14) 
equally well. 
The efficacy of antigen presentation might be enhanced 
if the specificity of the peptide translocator and class I MHC 
molecules were matched (15). Most mouse class I bound pep- 
tides contain a COOH-terminal hydrophobic amino acid (15, 
16) (H-2Kd:  L/I;  H-2Db:  M/I;  H-2Kb:  L/M;  H-2Kk:  I; 
H-2Kbml: I). Not all human class I alleles fit this pattern, 
as both Aw68 and B27 have a preference for COOH terminal 
R  or K (17, 18). A similar preference for a particular type 
of amino acid sidechain is not seen for the NH2-terminal res- 
idue or any other sequence position in class I-bound pep- 
tides. If peptides that bind to class I molecules would be im- 
mediate substrates for the TAP translocator (rather than larger 
precursors  with COOH-terminal extensions), then mouse 
TAP and class I molecules might share a preference for a hy- 
drophobic COOH terminus. We show here that the mouse 
TAP translocator preferentially accommodates peptides having 
a large hydrophobic COOH-terminal amino add. We also 
show that the TAP translocator transports peptides with a 
minimum length of nine amino adds, consistent with the 
length preference  of class I molecules. 
533  j. Exp. Med.  0  The Rockefeller University Press ￿9 0022-1007/94/02/0533/08  $2.00 
Volume 179  February 1994  533-540 Along with determining the peptide specificity of the TAP 
translocator, we also establish the presence of an ATP-depen- 
dent efflux mechanism that allows exit of peptides from the 
endoplasmic reticulum (ER) to the cytosol. In this manner, 
a low steady-state peptide concentration in the ER may be 
maintained such that class I molecules are preferentially loaded 
with  high  affinity peptides. 
Materials  and  Methods 
Antibodies, Peptides,  and Peptide  labeling.  All peptides were syn- 
thesized on a multiple peptide synthesizer (model 350; Advanced 
Chemtech, Louisville, KY), using conventional Pmoc chemistry. 
Purity of all peptides was assessed by TIC and subsequent nin- 
hydrin staining (N-butanol/HzO: pyridine/HOAc, 2:1:0.75:0.25, 
on Silicagel 60 phtes; EM Science, Gibbstown, NJ). Where re- 
quired (for the FAPGNYPAX series X  =  C, X  =  N, and X  = P), 
peptides were purified by HPI.C. Amino acid composition of the 
peptides X  =  L and X  =  G was confirmed by amino acid analysis. 
The identity of the peptides, X  =  D, X  =  F, X  =  L, and X  =  R 
was confirmed by sequencing.  The identity of peptides TYQIkTR- 
ALV, acetyI-FAPGNYPAL, FAPGNYPADamide,  APGNYPAL, 
PGNYPAL, and GNYPAL was confirmed by amino acid analysis. 
Peptides were dissolved in 0.1x PBS and filtered through 0.22-/~m 
filters. All peptides were readily sohble in aqueous solution up to 
2 raM. Peptide concentrations were determined by absorbance at 
275.5  nm (19). 
The peptide FAPGN (3H-)YPAL was prepared fxom a FAPGN- 
(di-iodo-)-YPAL precursor by reduction under 3H-gas (13, 20) and 
purified as described (13); this peptide binds to H-2  b molecules 
(21). The peptide TYNRTRALI was labeled by chloramine T-cata- 
lyzed iodination. Anti-TAP1 antibodies were obtained by immuni- 
zation of rabbits with purified mouse TAP1 ATP binding domain 
(the COOH-terminal 280 amino adds) obtained by expression in 
Escherichia  coil This serum has been described (22). The anti-TAP2 
serum was raised against the ATP binding domain of mouse TAP2 
and will be described dsewhere. 
Pre~mtion of  Microsomes  and Transport  Assal/s.  Microsomes were 
prepared  from livers  of 6-8-wk-old  female  C57B1/6  mike,  or 
C57BL/6,  129/SV,  and/~2-microglobulin  (/~an)-negative mice 
(129/SV  x  C57BL/6 F1), that had been primed with polyino- 
sinic-polycyt'idylic add (Sigma Chemical Co., St. Louis, MO) for 
24-36 h as described (13, 23). Transport assay mixtures were as- 
sembled on ice as described (13). Each mixture contained 5/~1 micro- 
somes (corresponding to 80-120/~g protein), 50 mM Hepes' pH 
7.2, 150 mM KOAc, pH 7.5, 5 mM MgOAc., 250 mM sucrose, 
0.2 pM FAPGN[SH]YPAL or 60 nM I~I-TYNRTRALI, 1 mM 
dithiothreitol, and where applicable,  ATP generating system (50 
/~M ATP, 250/LM UTP, 2.5 raM creatine phosphate, 8 U rabbit 
muscle creatine phosphokinase), and competitor peptides. Reac- 
tions were incubated at 23~  for 10 rain, and subsequently trans- 
ferred to ice. Samples were loaded on ice-cold 1-ml sucrose cushions 
(1 M.KOAc, pH 7.5, 500 mM sucrose,  50 mM Hepes, pH 7.2, 
and 25/~M unhbeled FAPGNYPAL). Samples were spun for 15 
min at 67,000 rpm in a rotor (TLA 100.2; Beckman Instruments, 
Inc., Fullerton, CA). Supematants were astfirated and pellets were 
resuspended in 150/~1 lysis mix (0.5% NP-40, 150 mM Tris-HC1, 
pH 7.4, 150 ram NaCI, 5 mM MgC12) by repeated Fipetting. De- 
bris was removed  by centrifugation at 14,000 g for 4 rain and soluble 
radioactivity was determined by scintillation counting. For all ex- 
periments shown, the ratio of peptide uptake in the presence and 
absence of ATP was at least a factor 3-3.5, and the total number 
of counts recovered varied between L500 and 6,000 cpm, varying 
both between different microsome preparations and different la- 
beled substrates. 
FACS  ~ Analysis of Upregulation of MHC Class I Expression. 
Stabilization of  class I molecules by peptide as measured by FACS  | 
analysis (Becton Dickinson & Co., Mountain View, CA) was per- 
formed as described (1). Briefly, RMA-S cells were incubated over- 
night in the presence  of 100/~M peptide for all peptides of the 
FAPGNYPAX series. Cells were subsequently stained with either 
B8-24-3 (anti-Kb; (American Type Culture Collection, Rockvilh, 
MD  [ATCC])  or  B22.249  (anti-D  b,  ATCC)  antibodies,  and  a 
second goat anti-mouse IgG FITC antibody. Mean fluorescence 
of labeied cells was determined by cytofluofimetric analysis. "-" 
indicates  0-33%  of maximal class I upregulation,  "+" indicates 
33-67% of maximal upregulation, and "+ +" indicates  67-100% 
of maximal class I upreguhtion. Chss I upregahtion was calcu- 
lated as (mean fluorescence in the presence of peptide)  -  (mean 
fluorescence in the absence of peptide). For both D b and K b, max- 
imal upregulation (an approximate threefold increase in class I ex- 
pression) was observed with the peptide FAPGNYPAV  (Table 1). 
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Figure  1.  Peptide  uptake by mouse microsomes  is reversible  in an ATP- 
dependent manner. Microsomes were loaded with [3H]FAPGNYPAL  at 
2.3~  in the absence (sample  A) or presence of ATP (samples B, C, and 
D), as described  in Materials and Method~ After the first incubation, micro- 
somes were spun down and resuspended  in fresh, [3H]FAPGNYPAL  free 
incubation buffer containing 200/aM unlabeled FAPGNYPAL. Samples 
C and D underwent a second incubation at 23eC in the presence or ab- 
sence of ATP. Microsomes were pelleted by centfifugation. Microsome- 
associated radioactivity was determined as described in Materials and 
Methods. Data show that efl]ux of hbeled peptide occurs in an ATP- 
dependent manner. Values given are means of duplicates +  SD. 
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Peptide Uptake by Mouse Microsomes Is Reversible in an ATP- 
and Temperature-dependent  Manner.  Peptide uptake in micro- 
somal vesicles is a rapid process that reaches equilibrium within 
10 min (13). This is not due to inactivation of TAP function 
in the course of incubation, because a 10-min preincubation 
in the absence of peptide does not affect subsequent peptide 
accumulation  (data not shown).  Rather, peptide efflux ap- 
pears to be responsible.  When microsomes are loaded with 
labeled peptide and subsequently  transferred to fresh medium, 
e~ux of labeled material  is observed in a temperature (data 
not shown)- and ATP-dependent fashion (Fig. 1). The mate- 
rial accumulated by and released from microsomes in the pres- 
ence of ATP is largely  intact  FAPGNYPAL,  as  shown by 
HPLC (data  not  shown). 
Efflux of FAPGNYPAL  may occur because the number 
of peptide molecules transported  into the microsomes is in 
excess of the number of available class I binding sites,  or be- 
cause other proteins in the ER (such as chaperones) might 
keep class I molecules in a state that would prevent high affinity 
capture  of substrate. 
Peptide Accumulation in Mouse Microsomes Is Influenced by 
the Presence of MHC Class I Products.  To test if manipula- 
tion of the number of available class I binding sites would 
affect peptide accumulation inside the microsomes, we made 
use of mice with a targeted disruption of the 32m gene (24). 
As a consequence of the lack of 32m,  neither K b nor D b is 
expected to fold correctly.  The resulting free H chains, while 
capable of binding peptide, do so only at very high concen- 
trations of peptide (25). As shown in Fig. 2 A, microsomal 
preparations  from 3zm-  mice fail to significantly accumu- 
late the [3H]FAPGNYPAL  substrate  in an ATP-dependent 
fashion. However, introduction of a consensus site for N-linked 
glycosylation  in  a  derivative  of  a  Kd-restricted  epitope 
(TYQRTRALV-*TYNRTRALI)  results  in a peptide that 
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Figure  2.  (.4)  [3H]FAPGNYPAL  accumulation  in mouse microsomes is dependent  on B2m.  C57B1/6  (H-2 b) and 129/SV (H-2  b) derived micro- 
somes but not C57B1/6  x  129/SV (H-2  b) B2m- derived microsomes  accumulate [3H]FAPGNYPAL  in an ATP-dependent  manner. Microsomes  were 
prepared as described in Materials and Methods, and tested for peptide accumuhtion, using the substrate 3[H]FAPGNYPAL. Values are means of duplicates 
+_  SD.  (B) B2m-  microsomes  accumulate  the glycosylation  substrate 12SI-TYNRTRALI  in an ATP- and TAP-dependent  fashion.  Microsomes  were 
incubated as described in Materials and Methods in the presence of 60 nM t2SI-TYNRTRALI.  Microsomes  were preincubated on ice with 2/~1 an- 
tiserum  for  10 min in a total volume of 50 #1.  Anti-HC is a rabbit antiserum  raised against  the human MHC class I H  chain,  rabbit anti-TAP1/2 
sera are directed against  the ATP binding domains of mouse TAP1 and TAP2.  Values are means of duplicates  +  SD.  (C) TAP-  microsomes  do not 
accumulate the glycosylation  substrate I~I-TYNRTRALI.  Microsomes  were prepared from wild-type age-matched male C57B1/6 and TAP-  (C57B1/6 
x  129/SV) mice and tested for uptake of the peptide  t2SI-TYNRTALI as described in Materials and Methods.  Values are means of duplicates  _+  SD. 
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(Fig.  2 B). This phenomenon is TAP dependent since it is 
not observed for microsomes derived from TAP1 mutant mice 
(Fig.  2 C), and Peptide uptake can be inhibited by TAPl- 
and TAP2-specific antibodies (Fig. 2 B). The attachment of 
an N-linked glycan is observed  for this peptide after uptake 
by rat microsomes, a property that could explain its reten- 
tion (25a). 
Thus, accumulation of FAPGNYPAL in microsomal vesicles 
requires  an intact/32m gene, and therefore binding to class 
I molecules affects the outcome of such translocation assays. 
Alternatively, the presence of a glycosylation  site in the trans- 
location substrate renders the assay independent of class I 
binding sites. 
In previous experiments (13) we observed  that the K d- 
restricted Peptide TYQRTRALV was a far worse compet- 
itor  than  the  Kb-restricted  peptide  FAPGNYPAL  when 
tested for competition of uptake of [3H]FAPGNYPAL by 
H-2  b microsomes.  These results are in contrast with the ob- 
servation  that  the  TYQRTRALV  Peptide  is  presented 
efficiently, and without a need for flanking sequences, when 
expressed in the cytosol of murine cells (26).  When these 
two Peptides  are tested for competition of 12SI-TYNRTR- 
ALl  uptake  using  /32m-  microsomes,  no  differences  in 
efficiency of competition  are  observed  (Fig.  3).  Identical 
ICs0s (competitor concentration at which substrate uptake 
is half-maximal) for these two Peptides (3 #M) are also found 
when tested using H-2d-derived microsomes (Schumacher, 
T. N. M., unpublished observations). 
Thus  in assays where the labeled substrate can bind to the 
class I molecules present, peptide accumulation in microsomes 
may reflect the combined effects of two parameters:  compe- 
tition for TAP-mediated transport and competition for class 
I binding sites in the microsomes. To exclude  a bias intro- 
duced by class I binding, all further experiments were per- 
formed using 32m- microsomes and the glycosylation sub- 
strate. 
The Mouse  TAP Translocator Prefers Peptides  with a Hydro- 
phobic COOH  Terminus.  The peptides bound to all mouse 
class I products studied thus far are characterized by a hydro- 
Table  1.  ICso Values of FAPGNYPAL and FAPGNYPAL 
Derivatives in ~m-  Microsomes 
Class I binding 
ICs0 
Competitor X =  K b  D b  FAPGNYPAX 
/~M 
Leucine*  + +  +  5.2 
Methionine  + +  +  6.4 
Tyrosine  -  -  6.4 
Tryptophan  -  -  7.1 
Isoleucine  + +  + +  7.2 
Phenylalanine  -  -  8.3 
Valine  + +  + +  28.0 
Glutamine  -  -  36.0 
Cysteine  + +  +  57.0 
Threonine  -  +  >100.0 
Alanine  +  + +  >100.0 
Histidine  -  -  >100.0 
Lysine  -  -  >100.0 
Asparagine  -  -  >100.0 
Proline  -  +  >100.0 
Serine  -  -  >100.0 
Glutamic acid  -  -  >100.0 
Aspartic acid  -  -  >100.0 
Glycine  -  -  >100.0 
Arginine  -  -  >100.0 
*  Measured using/32m- microsomes,  and 12SI-TYNRTRALI  substrate. 
phobic COOH-terminal amino acid (15, 16). To explore the 
possibility that class I molecules and the TAP translocator 
might have a shared  specificity for a hydrophobic COOH 
terminus, we synthesized FAPGNYPAL and the 19 other pos- 
sible COOH-terminal substitutions and assayed  them for their 
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Figure  3.  Two peptides  that  only share  a hydrophobic 
COOH terminus  compete with similar efficiency for TAP- 
mediated  peptide  uptake.  The peptides  FAPGNYPAL  and 
TYQRTRALV were tested for competition  in uptake of 12sI- 
TYRTRALI as described in Materials and Methods.  Values 
are given as a percentage of maximal 12SI-TYNRTRALI up- 
take and were calculated as described in Table 2. Data show 
that unlike for wild-type microsomes (13), an H-2  d- and an 
H-2b-restricted  epitope  compete with similar efficiency for 
uptake of an H-2Kd-restricted epitope when tested in Bzm- 
microsomes. 
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fl2m- liver microsomes (Table 1). A strong correlation be- 
tween the ability of an analog to compete for uptake, and 
the presence of an aliphatic or aromatic residue at the COOH 
terminus is observed.  Among those peptides that compete 
for uptake of nSI-TYNRTRALI,  only those ending in a 
nonaromatic, hydrophobic residue (L,I,V,M), and Cys are able 
to bind to and stabilize H-2 D b and K b molecules (Tables 
1 and 2). 
The effect of competition for class I binding sites in this 
type of translocation assay was examined using wild-type 
microsomes and the H-2  b binding peptide 3H-FAPGNY- 
PAL. Under these conditions, where the ability of the sub- 
strate to combine with ER-resident class I molecules is crucial 
to observe peptide accumulation (Fig. 2 A), those peptides 
that will bind to the dass I molecules present compete far 
more efficiently than those that do not (Table 3). 
The  TAP  Peptide Translocator Prefers Peptides  with  Free 
ot-NH2 and -COOH Groups of a Minimum  Length  of Nine 
Amino Acids.  Replacement of a free COOH terminus with 
a COOH-terminal amide reduces efficacy of competition, as 
does acetylation of the NH2 terminus (Table 2), suggesting 
that the presence  or proper positioning of free c~-NH2 and 
-COOH  groups may facilitate transport. 
Truncation  of FAPGNYPAL  from  the  NH2  terminus 
leads to a dramatic loss of inhibitory capacity such that the 
octamer APGNYPAL is no longer a good competitor for 
uptake of nSI-TYNRTRALI (Fig.  4).  However, peptides 
Table  2.  The  TAP Transporter Prefers Peptides with Free 
Peptide Termini 
Competitor  ICso 
FAPGNYPAL*  5.2 
FAPGNYPALG  >too.o 
FAPGNYPALGG  >1oo.o 
Acet  y  I - FAPGNYPAL  >1oo.0 
FAPGNYPAL- am i de  >100.0 
The peptides FAPGNYPAX (in which X is any of the 20 naturally  oc- 
curring amino adds) were tested for inhibition  of uptake of lzs-I TYNK- 
TRALI. Peptides  are denoted  by their COOH-terminal  residues in single 
letter code. All values are means of duplicates and were expressed and 
plotted as a percentage  of maximal  FAPGN[3H]YPAL  uptake: 100% x 
[uptake  (+ ATP,  +competitor)]- [uptake  (-ATP)]/[uptake 
(+ ATP)]- [uptake (-ATP)].  ICs0 values were calculated based on 
curves as shown in Fig. 3 ICs0 is defined  as the concentration  of com- 
petitor at which uptake of the lzSI-TYNKTRALI  peptide is half  max- 
imal. Class I stabilization was assayed as described previously  (1). The 
peptide TYNR.TRALI  was labeled by chloramine T-catalyzed  iodina- 
tion to a specific  activity  of ~30 Ci/mmol, and was used under condi- 
tions described in Materials  and Methods, at a concentration  of 60 riM. 
Note that the FAPGNYPAL peptide, but not the TYNRTRALI/ 
TYQKTRALX peptides, contain  the anchor residues found  in both K  b 
and D  b bound peptides. 
* Measured using flzm- microsomes,  and ~I-TYNKTRALI  substrate. 
carrying NH2-terminal  extensions of up  to  four residues 
compete as effidently  as does the nine-residue peptide (Fig. 4). 
COOH-terminal extensions of FAPGNYPAL consisting 
of Gly or Gly-Gly greatly impair the ability of these longer 
peptides to serve as substrates for the TAP translocator (Table 
2),  consistent with the preference  for a large hydrophobic 
COOH-terminal residue. Thus, the presence within a longer 
peptide of a nonamer that is itself translocated efficiently, is 
not sufficient to drive translocation. 
Discussion 
The Peptide Preference of the  TAP Translocator and Class 1 
Molecules Is Similar but Not Identical.  The TAPl-TAP2 com- 
plex translocates peptides with an aromatic or large aliphatic 
COOH  terminus.  Peptides  having an  aromatic  COOH- 
terminal residue, although effective competitors for transport 
(Table 1), are sddom seen associated with mouse class I mol- 
ecules (15). Conversely,  some peptides that can bind to class 
Table  3.  ICso Values of FAPGNYPAL and FAPGNYPAL 
Derivatives in B6 Microsomes 
Competitor 
FAPGNYPAX,  X =  ICs0 
Isoleucine  0.1 
Leucine  0.1 
Methionine  0.1 
Valine  0.4 
Cysteine  0.6 
Phenylalanine  0.8 
Tryptophan  1 
Tyrosine  3 
Threonine  7 
Alanine  14 
Glutamine  36 
Histidine  66 
Lysine  66 
Asparagine  82 
Proline  >100.0 
Serine  >100.0 
Glutamic acid  >10010 
Aspartic acid  >100.0 
Glycine  >100.0 
Arginine  >100.0 
ICs0 is defined  as the concentration of competitor at which uptake of 
the [3H]FAPGNYPAL peptide is half  maximal. Competition  experi- 
ments were performed  using  B6 microsomes  and [3H]FAPGNYPAL  sub- 
strate. Data show (together with the data in Table 1) the eff~'t of 
competition for MHC class I binding sites on peptide accumulation  in 
microsomes. 
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Figure 4.  The TAP peptide  translocator  prefers  peptides  of a minimum 
length  of 9 amino  acids. Peptide$ tested  were  the following:  GGTTFAPG- 
NYPAL, GGTFAPGNYPAL,  GGFAPGNYPAL,  GFAPGNYPAL,  FAPG- 
NYPAL, APGNYPAL, PGNYPAL, and GNYPAL ICso values were 
determined  from titration  curves  as shown  in Fig. 3. Peptide  uptake e~- 
periments were performed  as described  in Materials and Methods. 
I molecules appear to be poor substrates for the peptide trans- 
porter (e.g., FAPGNYPAA, Table 1). TAP may therefore act 
as a restriction point in antigen presentation (27,  28). 
The observation that the preference of the TAP translo- 
cator for a hydrophobic COOH terminus matches the prefer- 
ence of mouse class I products suggests that the COOH ter- 
minus of peptides that  are  translocated might be  direct 
substrates  for the class I molecules present. However, the 
human HLA-B27 class I product, which has a strong prefer- 
ence for peptides terminating in Lys or Arg (17), can present 
peptides e/ficiently when tramfected into mouse cells (Rowland 
Jones, A., personal communication). As peptides terminating 
in Lys and Arg are not transported well by the mouse TAP 
peptide translocator (Table 1), (a) precursor(s) with COOH- 
terminal extensions could be transported, and trimmed to 
the proper length after arrival in the ER. It remains to be 
determined whether in human cells, those alleles that prefer 
basic residues at the COOH terminus (thus far shown for 
Aw68 and B27) rely on COOH-terminal trimming of pep- 
tides in the ER, or that the specificity of the human trans- 
porter includes those basic COOH-terminal residues. 
The Transport  of  poptides Longer than Nine Amino Acids Sug- 
gests the Possibility of ER Processing.  Presentation of a 12- 
residue peptide encoded by a minigene has been shown to 
require both a functional TAP complex and ER-directed ex- 
pression of a  carboxypeptidase (26).  Furthermore,  TAP- 
dependent association of a subpopulation of HLA-B27 mole- 
cules with peptides up to 30 residues long in human ceUs 
has been observed (28a). Both these observations suggest that 
TAP may translocate peptides longer than those usually found 
associated with class I molecules. The experiments described 
here  show  directly that  TAP transports  peptides with  a 
minimum length of nine amino acids. Consequently, many 
of the peptides that arrive in the lumen of the ER will re- 
quire additional trimming by amino-peptidases and carboxy- 
peptidases in order to convert them to high affinity, class I 
binding peptides. Since longer peptides can combine with 
class I molecules, albeit it with lower atfinity (29), such trim- 
ming may weU occur after binding. 
The ability of TAP to transport peptides longer than those 
usually found associated with class I molecules may serve to 
increase the dficiency of antigen presentation. If only pep- 
tides of 8-10 amino acids ending in a hydrophobic residue 
could be transported, most of these sequences would contain 
only part of a presentable peptide. For instance,  the Sendai 
nucleoprotein sequence KDFVHGE_FAPGNYPALWSYA 
could produce many peptides of 8-10 amino adds ending in 
a hydrophobic amino acid compatible with translocation (un- 
derlined) of which only three (EFAPGNYPAL,  FAPG- 
NYPAL, and FAPGNYPALW) would contain a sequence 
that can bind to H-2  b molecules, the others containing only 
part of the H-2Kb-restricted epitope. Thus, the transport of 
peptides longer than those usually found associated with class 
I molecules increases the chance of transporting fragments 
containing a peptide that can bind to the class I molecules 
present. 
Peptide E.~ux Provides a Mechanism for the Accumulation of 
High-a~nity Peptides by Class I Molecules.  The accumulation 
of peptide in mouse microsomes is dependent on retention 
of the substrate. In the case of the FAPGNYPAL peptide this 
retention is likely to be caused by combination with MHC 
class I molecules, as it is dependent on the presence of flzm. 
However,  unlike for ceU surfaee-disposed class I molecules, 
the binding of this peptide to the class I molecules that re- 
side in the microsomal EtL equivalents is rapidly reversible: 
a temperature- and ATP-dependent efflux of peptide is ob- 
served. Association of ER-rcsident class I molecules with a 
heat shock protein type-chaperonin might result in a popu- 
lation  of class  I  molecules with  a  more relaxed  binding 
spedficity, capable of exchanging peptides rapidly, until dis- 
sociation of the chaperone would lead to a quasi "irrevers- 
ible" capture of substrate.  In this model, the observed ATP 
dependency for peptide egress either could be imposed by 
the putative class I bound chaperonin, or by the proteins in- 
volved in delivery of peptide back to the cytosol. This/these 
protein(s) may not be the TAP1-TAP2 complex, as antibodies 
directed against TAP1 and TAP2 fail to inhibit the efflux of 
peptide (Schumacher, T. N. M., unpublished observations). 
If  TAP were to transport a very similar set of peptides regard- 
less of MHC haplotype (the rat is an exception [8, 25a), as 
suggested by the very limited polymorphism  in the TAP genes 
538  Peptide  Length  and Sequence  Specificity  of Mouse TAP1/TAP2  Translocator (30),  then most of the peptides in the EK would be of low 
affinity or would not fit the class I molecules present. By 
continuously perfusing the ER with peptides at low steady 
state concentrations-a possibility suggested by our data- 
ER-resident empty class I molecules can sample the peptides 
that pass and retain those with the best fit. This mode of 
accumulation of high-affinity  peptides bound to class I mol- 
ecules could explain the occurrence of class I-restricted epi- 
topes only in the presence  of the corresponding restriction 
dement (31). 
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